Matches in Wikidata for { <http://www.wikidata.org/entity/Q72407001> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q72407001 description "artikull shkencor i botuar më 01 janar 1984" @default.
- Q72407001 description "artículu científicu espublizáu en xineru de 1984" @default.
- Q72407001 description "im Jahr 1984 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72407001 description "scientific article published on 01 January 1984" @default.
- Q72407001 description "wetenschappelijk artikel" @default.
- Q72407001 description "наукова стаття, опублікована в січні 1984" @default.
- Q72407001 name "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT)" @default.
- Q72407001 name "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation" @default.
- Q72407001 type Item @default.
- Q72407001 label "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT)" @default.
- Q72407001 label "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation" @default.
- Q72407001 prefLabel "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT)" @default.
- Q72407001 prefLabel "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation" @default.
- Q72407001 P1433 Q72407001-C98F6AA4-77D6-46A2-81E7-8F866AE6768D @default.
- Q72407001 P1476 Q72407001-9AB90A97-244E-4A12-BE80-0199AB61094F @default.
- Q72407001 P2093 Q72407001-39508AF7-9D7E-4DD8-A6E4-D3149E9205CA @default.
- Q72407001 P2093 Q72407001-3E27F02B-A972-4188-98E8-E150D53C31FB @default.
- Q72407001 P2093 Q72407001-BCD6F22B-CF8B-4DB1-810F-5A2A951F64CD @default.
- Q72407001 P2093 Q72407001-C04221FC-15A3-4B38-8FD5-0D6133E6AC69 @default.
- Q72407001 P2093 Q72407001-CA40CF62-D4C9-493A-9E63-71995026E7D9 @default.
- Q72407001 P2093 Q72407001-EF5E1613-87C3-4971-9B35-9B9036F18504 @default.
- Q72407001 P304 Q72407001-A5C85490-084C-49D6-8F29-B8A57DF54987 @default.
- Q72407001 P31 Q72407001-266F49C0-CBCD-4BBC-BB88-9E2500E5FA5F @default.
- Q72407001 P433 Q72407001-CE1065CF-31E7-4426-87F1-249616923725 @default.
- Q72407001 P478 Q72407001-225105CE-145A-405D-9AC6-CB39EC92B495 @default.
- Q72407001 P50 Q72407001-B1DD2DF1-4808-4126-8CA5-46498C78D365 @default.
- Q72407001 P50 Q72407001-D4D7A41F-5D66-4350-B0E9-EA0A79DC4806 @default.
- Q72407001 P577 Q72407001-841F6570-7194-4F04-9E7E-2E78B5CAB4FE @default.
- Q72407001 P698 Q72407001-8914E624-D3BD-4D91-99A7-7C940583FD73 @default.
- Q72407001 P921 Q72407001-61990232-1FB0-4ED4-9523-26F6886B06C3 @default.
- Q72407001 P698 6096742 @default.
- Q72407001 P1433 Q26842171 @default.
- Q72407001 P1476 "Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT)" @default.
- Q72407001 P2093 "Meinesz AF" @default.
- Q72407001 P2093 "Mulder NH" @default.
- Q72407001 P2093 "Orie JL" @default.
- Q72407001 P2093 "Sleijfer DT" @default.
- Q72407001 P2093 "Van der Geest S" @default.
- Q72407001 P2093 "Vriesendorp R" @default.
- Q72407001 P304 "389-392" @default.
- Q72407001 P31 Q13442814 @default.
- Q72407001 P433 "10" @default.
- Q72407001 P478 "27" @default.
- Q72407001 P50 Q56826661 @default.
- Q72407001 P50 Q64712784 @default.
- Q72407001 P577 "1984-01-01T00:00:00Z" @default.
- Q72407001 P698 "6096742" @default.
- Q72407001 P921 Q418817 @default.